Giredestrant significantly improved IDFS in ER-positive, HER2-negative early breast cancer, reducing recurrence or death risk by 30% compared to SOC endocrine therapy. Subgroup analyses showed ...
The College of Psychologists and Behaviour Analysts of Ontario is proposing reducing the number of supervised work years for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback